News + Filings Transactions
|
Ibrahim Ramy
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2023 | 2seventy bio, Inc. | | Grant | | 8.4k | $0.00 | $0 | | 06/13/2023 |
| 06/13/2023 | 2seventy bio, Inc. | | Grant | Stock Option (right to buy) | 16.9k | $11.81 | $199.6k | | 06/13/2023 |
| 06/08/2022 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 24k | $2.01 | $48.2k | | 06/08/2022 |
| 06/08/2022 | 2seventy bio, Inc. | | Grant | | 7.2k | $0.00 | $0 | | 06/08/2022 |
| 06/08/2022 | 2seventy bio, Inc. | | Grant | Stock Option (right to buy) | 14.4k | $13.51 | $194.5k | | 06/08/2022 |
| 11/11/2021 | 2seventy bio, Inc. | | Grant | Stock Option (right to buy) | 3.2k | $50.98 | $164.1k | | 11/11/2021 |
| 11/11/2021 | 2seventy bio, Inc. | | Grant | Stock Option (right to buy) | 2.9k | $75.10 | $217.6k | | 11/11/2021 |
| 11/11/2021 | bluebird bio, Inc. | BLUE | Other (disposition) | Stock Option (right to buy) | 4.5k | $0.00 | $0 | | 11/11/2021 |
| 11/11/2021 | bluebird bio, Inc. | BLUE | Other (disposition) | Stock Option (right to buy) | 5k | $0.00 | $0 | | 11/11/2021 |
| 11/11/2021 | 2seventy bio, Inc. | | Grant | | 2k | $0.00 | $0 | | 11/11/2021 |
| 11/11/2021 | 2seventy bio, Inc. | | Grant | | 1.4k | $0.00 | $0 | | 11/11/2021 |
| 06/15/2021 | bluebird bio, Inc. | BLUE | Grant | | 3.1k | $0.00 | $0 | | 06/15/2021 |
| 06/15/2021 | bluebird bio, Inc. | BLUE | Grant | Stock Option (right to buy) | 5k | $32.83 | $164.2k | | 06/15/2021 |
| 06/08/2021 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 17.7k | $7.69 | $136.1k | | 06/08/2021 |
| 01/07/2021 | bluebird bio, Inc. | BLUE | Grant | | 2.2k | $0.00 | $0 | | 01/07/2021 |
| 01/07/2021 | bluebird bio, Inc. | BLUE | Grant | Stock Options (Right to buy) | 4.5k | $48.36 | $217.6k | | 01/07/2021 |
| 06/10/2020 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 12k | $4.35 | $52.2k | | 06/10/2020 |
| 10/01/2019 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 24.2k | $1.17 | $28.3k | | 10/01/2019 |
|